Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)252-255
Number of pages4
JournalOncologist
Volume4
Issue number3
DOIs
StatePublished - 1999

Keywords

  • Antimetabolites, Antineoplastic/pharmacology
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • Cisplatin/administration & dosage
  • Clinical Trials as Topic
  • Deoxycytidine/analogs & derivatives
  • Gemcitabine
  • Humans
  • Lung Neoplasms/drug therapy
  • Practice Guidelines as Topic
  • Research/trends
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.'. Together they form a unique fingerprint.

Cite this